Overview
Sigma Healthcare is a large Australian pharmacy wholesaler and franchisor, with a business spanning medicine distribution, pharmacy brands and services that support community pharmacies. Revenue growth of 31.90% highlights recent expansion, while the 6.55% profit margin and a price-to-earnings ratio of 43.3 times frame the key question for investors: how effectively can that scale and growth translate into durable earnings?
Sigma Healthcare combines pharmaceutical wholesale distribution with retail pharmacy franchising and support services. It supplies pharmaceutical, medical, healthcare and beauty products to community pharmacies and other third parties, while also providing advertising, marketing and medication-management services. Its pharmacy brands include Chemist Warehouse, Amcal, Discount Drug Stores and PriceSave. This mix gives the business exposure to both the essential medicines supply chain and consumer-facing pharmacy retail, with revenue of A$10.8 billion and a market capitalisation of A$29.9 billion in the supplied figures.
Key facts
- Ticker
- SIG
- Exchange
- AU
- ISIN
- AU000000SIG5
- Sector
- Healthcare
- Industry
- Medical Distribution
- Country
- Australia
- Currency
- AUD
- Price
- A$2.62
- Previous close
- A$2.62
- Day change
- A$0.00 (0.00%)
- Market cap
- 30.1B
- 52W low
- A$2.47
- 52W high
- A$3.15
Price and trend
Last price: A$2.62
- Price
- A$2.62
- 52W range
- A$2.47 – A$3.15
- 50-day SMA
- A$2.74
- 200-day SMA
- A$2.82
- Price vs 50D SMA
- -4.37%
- Price vs 200D SMA
- -7.18%
Valuation
- P/E
- 43.67
- EPS
- 0.06
- Dividend yield
- 1.52%
- Beta
- 0.32
Sigma’s scale and reported revenue growth of 31.90% are notable, but the 6.55% profit margin shows that a comparatively small share of revenue is retained as profit. At 43.3 times earnings, the valuation leaves the shares sensitive to whether growth can translate into sustained earnings. The dividend yield is 1.56%, with a reported dividend per share of A$0.04, so income is one part of the profile rather than its defining feature.
Profitability and growth
- Revenue growth
- 31.90%
- Revenue TTM
- 10.8B
- Profit margin
- 6.55%
Analyst view
Comparison uses the last price shown; targets are analyst estimates.
Top Australian Brokers
- Pepperstone - Top Australian broker - Read our review
- eToro - Invest in ASX and international shares - Read our review
- Price
- A$2.62
- Target price
- A$3.20
- Target vs last price
- 22.06% from last price
The supplied target price is A$3.20, or 23.00% from the last price of A$2.60. That figure is a secondary reference point rather than a reliable forecast: the company’s operating performance, competitive conditions and valuation remain central to the investment story.
Risks
Sigma’s 6.55% profit margin leaves profitability sensitive to costs and operational pressures across its large distribution and pharmacy-support business. Its 43.3 times price-to-earnings ratio also places weight on the company sustaining growth. The share price is below both supplied moving averages and remains within a 52-week range of A$2.47 to A$3.15, underscoring that recent price movements can cut both ways.
FAQ
What does Sigma Healthcare do?
Sigma distributes pharmaceutical, medical, healthcare and beauty products to community pharmacies, supports a network of franchised pharmacies and provides services including advertising, marketing and medication management.
How large is Sigma Healthcare?
The supplied figures put its market capitalisation at A$29.9 billion and trailing revenue at A$10.8 billion.
Does Sigma Healthcare pay a dividend?
The supplied dividend yield is 1.56%, with a dividend per share of A$0.04. These figures describe the reported dividend profile and do not guarantee future payments.
How is SIG trading relative to its recent range and moving averages?
At A$2.60, the share price sits within its 52-week range of A$2.47 to A$3.15. It is below the supplied 50-day and 200-day moving averages of A$2.77 and A$2.83, respectively.
*This content is aimed to provide general information only, and does not take your personal objectives, financial situation or needs into account.
